Ewing Sarcoma Drugs Market, Global Outlook and Forecast 2022-2028

April 2022 | 106 pages | ID: E635AA15B3A2EN
Market Monitor Global

Abstracts

Ewing sarcoma is a cancerous tumor that grows in the bones or in the tissue around bones (soft tissue)—often the legs, pelvis, ribs, arms or spine. Ewing sarcoma can spread to the lungs, bones and bone marrow.

This report contains market size and forecasts of Ewing Sarcoma Drugs in Global, including the following market information:

Global Ewing Sarcoma Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Ewing Sarcoma Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Vincristine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Ewing Sarcoma Drugs include Merck, Roche, GlaxoSmithKline, Novartis, Pfizer, Johnson & Johnson, Bristol-Myers Squibb, Sanofi and Abbott, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ewing Sarcoma Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Ewing Sarcoma Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Ewing Sarcoma Drugs Market Segment Percentages, by Type, 2021 (%)

• Vincristine
• Cyclophosphamide
• Doxorubicin
• Etoposide
• Ifosfamide
• Dactinomycin

Global Ewing Sarcoma Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Ewing Sarcoma Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Homecare
• Specialty Clinics
• Others

Global Ewing Sarcoma Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Ewing Sarcoma Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Ewing Sarcoma Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Ewing Sarcoma Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• Roche
• GlaxoSmithKline
• Novartis
• Pfizer
• Johnson & Johnson
• Bristol-Myers Squibb
• Sanofi
• Abbott
• Bausch Health
• Eli Lilly
• AbbVie
• Takeda Pharmaceutical
• Amgen
• AstraZeneca
• Eisai
• Incyte Corporation

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Ewing Sarcoma Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Ewing Sarcoma Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EWING SARCOMA DRUGS OVERALL MARKET SIZE

2.1 Global Ewing Sarcoma Drugs Market Size: 2021 VS 2028
2.2 Global Ewing Sarcoma Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Ewing Sarcoma Drugs Players in Global Market
3.2 Top Global Ewing Sarcoma Drugs Companies Ranked by Revenue
3.3 Global Ewing Sarcoma Drugs Revenue by Companies
3.4 Top 3 and Top 5 Ewing Sarcoma Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Ewing Sarcoma Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ewing Sarcoma Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Ewing Sarcoma Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Ewing Sarcoma Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Ewing Sarcoma Drugs Market Size Markets, 2021 & 2028
  4.1.2 Vincristine
  4.1.3 Cyclophosphamide
  4.1.4 Doxorubicin
  4.1.5 Etoposide
  4.1.6 Ifosfamide
  4.1.7 Dactinomycin
4.2 By Type - Global Ewing Sarcoma Drugs Revenue & Forecasts
  4.2.1 By Type - Global Ewing Sarcoma Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Ewing Sarcoma Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Ewing Sarcoma Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Ewing Sarcoma Drugs Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Homecare
  5.1.4 Specialty Clinics
  5.1.5 Others
5.2 By Application - Global Ewing Sarcoma Drugs Revenue & Forecasts
  5.2.1 By Application - Global Ewing Sarcoma Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Ewing Sarcoma Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Ewing Sarcoma Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Ewing Sarcoma Drugs Market Size, 2021 & 2028
6.2 By Region - Global Ewing Sarcoma Drugs Revenue & Forecasts
  6.2.1 By Region - Global Ewing Sarcoma Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Ewing Sarcoma Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Ewing Sarcoma Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Ewing Sarcoma Drugs Revenue, 2017-2028
  6.3.2 US Ewing Sarcoma Drugs Market Size, 2017-2028
  6.3.3 Canada Ewing Sarcoma Drugs Market Size, 2017-2028
  6.3.4 Mexico Ewing Sarcoma Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Ewing Sarcoma Drugs Revenue, 2017-2028
  6.4.2 Germany Ewing Sarcoma Drugs Market Size, 2017-2028
  6.4.3 France Ewing Sarcoma Drugs Market Size, 2017-2028
  6.4.4 U.K. Ewing Sarcoma Drugs Market Size, 2017-2028
  6.4.5 Italy Ewing Sarcoma Drugs Market Size, 2017-2028
  6.4.6 Russia Ewing Sarcoma Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Ewing Sarcoma Drugs Market Size, 2017-2028
  6.4.8 Benelux Ewing Sarcoma Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Ewing Sarcoma Drugs Revenue, 2017-2028
  6.5.2 China Ewing Sarcoma Drugs Market Size, 2017-2028
  6.5.3 Japan Ewing Sarcoma Drugs Market Size, 2017-2028
  6.5.4 South Korea Ewing Sarcoma Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Ewing Sarcoma Drugs Market Size, 2017-2028
  6.5.6 India Ewing Sarcoma Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Ewing Sarcoma Drugs Revenue, 2017-2028
  6.6.2 Brazil Ewing Sarcoma Drugs Market Size, 2017-2028
  6.6.3 Argentina Ewing Sarcoma Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Ewing Sarcoma Drugs Revenue, 2017-2028
  6.7.2 Turkey Ewing Sarcoma Drugs Market Size, 2017-2028
  6.7.3 Israel Ewing Sarcoma Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Ewing Sarcoma Drugs Market Size, 2017-2028
  6.7.5 UAE Ewing Sarcoma Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck Ewing Sarcoma Drugs Major Product Offerings
  7.1.4 Merck Ewing Sarcoma Drugs Revenue in Global Market (2017-2022)
  7.1.5 Merck Key News
7.2 Roche
  7.2.1 Roche Corporate Summary
  7.2.2 Roche Business Overview
  7.2.3 Roche Ewing Sarcoma Drugs Major Product Offerings
  7.2.4 Roche Ewing Sarcoma Drugs Revenue in Global Market (2017-2022)
  7.2.5 Roche Key News
7.3 GlaxoSmithKline
  7.3.1 GlaxoSmithKline Corporate Summary
  7.3.2 GlaxoSmithKline Business Overview
  7.3.3 GlaxoSmithKline Ewing Sarcoma Drugs Major Product Offerings
  7.3.4 GlaxoSmithKline Ewing Sarcoma Drugs Revenue in Global Market (2017-2022)
  7.3.5 GlaxoSmithKline Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Ewing Sarcoma Drugs Major Product Offerings
  7.4.4 Novartis Ewing Sarcoma Drugs Revenue in Global Market (2017-2022)
  7.4.5 Novartis Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Ewing Sarcoma Drugs Major Product Offerings
  7.5.4 Pfizer Ewing Sarcoma Drugs Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 Johnson & Johnson
  7.6.1 Johnson & Johnson Corporate Summary
  7.6.2 Johnson & Johnson Business Overview
  7.6.3 Johnson & Johnson Ewing Sarcoma Drugs Major Product Offerings
  7.6.4 Johnson & Johnson Ewing Sarcoma Drugs Revenue in Global Market (2017-2022)
  7.6.5 Johnson & Johnson Key News
7.7 Bristol-Myers Squibb
  7.7.1 Bristol-Myers Squibb Corporate Summary
  7.7.2 Bristol-Myers Squibb Business Overview
  7.7.3 Bristol-Myers Squibb Ewing Sarcoma Drugs Major Product Offerings
  7.7.4 Bristol-Myers Squibb Ewing Sarcoma Drugs Revenue in Global Market (2017-2022)
  7.7.5 Bristol-Myers Squibb Key News
7.8 Sanofi
  7.8.1 Sanofi Corporate Summary
  7.8.2 Sanofi Business Overview
  7.8.3 Sanofi Ewing Sarcoma Drugs Major Product Offerings
  7.8.4 Sanofi Ewing Sarcoma Drugs Revenue in Global Market (2017-2022)
  7.8.5 Sanofi Key News
7.9 Abbott
  7.9.1 Abbott Corporate Summary
  7.9.2 Abbott Business Overview
  7.9.3 Abbott Ewing Sarcoma Drugs Major Product Offerings
  7.9.4 Abbott Ewing Sarcoma Drugs Revenue in Global Market (2017-2022)
  7.9.5 Abbott Key News
7.10 Bausch Health
  7.10.1 Bausch Health Corporate Summary
  7.10.2 Bausch Health Business Overview
  7.10.3 Bausch Health Ewing Sarcoma Drugs Major Product Offerings
  7.10.4 Bausch Health Ewing Sarcoma Drugs Revenue in Global Market (2017-2022)
  7.10.5 Bausch Health Key News
7.11 Eli Lilly
  7.11.1 Eli Lilly Corporate Summary
  7.11.2 Eli Lilly Business Overview
  7.11.3 Eli Lilly Ewing Sarcoma Drugs Major Product Offerings
  7.11.4 Eli Lilly Ewing Sarcoma Drugs Revenue in Global Market (2017-2022)
  7.11.5 Eli Lilly Key News
7.12 AbbVie
  7.12.1 AbbVie Corporate Summary
  7.12.2 AbbVie Business Overview
  7.12.3 AbbVie Ewing Sarcoma Drugs Major Product Offerings
  7.12.4 AbbVie Ewing Sarcoma Drugs Revenue in Global Market (2017-2022)
  7.12.5 AbbVie Key News
7.13 Takeda Pharmaceutical
  7.13.1 Takeda Pharmaceutical Corporate Summary
  7.13.2 Takeda Pharmaceutical Business Overview
  7.13.3 Takeda Pharmaceutical Ewing Sarcoma Drugs Major Product Offerings
  7.13.4 Takeda Pharmaceutical Ewing Sarcoma Drugs Revenue in Global Market (2017-2022)
  7.13.5 Takeda Pharmaceutical Key News
7.14 Amgen
  7.14.1 Amgen Corporate Summary
  7.14.2 Amgen Business Overview
  7.14.3 Amgen Ewing Sarcoma Drugs Major Product Offerings
  7.14.4 Amgen Ewing Sarcoma Drugs Revenue in Global Market (2017-2022)
  7.14.5 Amgen Key News
7.15 AstraZeneca
  7.15.1 AstraZeneca Corporate Summary
  7.15.2 AstraZeneca Business Overview
  7.15.3 AstraZeneca Ewing Sarcoma Drugs Major Product Offerings
  7.15.4 AstraZeneca Ewing Sarcoma Drugs Revenue in Global Market (2017-2022)
  7.15.5 AstraZeneca Key News
7.16 Eisai
  7.16.1 Eisai Corporate Summary
  7.16.2 Eisai Business Overview
  7.16.3 Eisai Ewing Sarcoma Drugs Major Product Offerings
  7.16.4 Eisai Ewing Sarcoma Drugs Revenue in Global Market (2017-2022)
  7.16.5 Eisai Key News
7.17 Incyte Corporation
  7.17.1 Incyte Corporation Corporate Summary
  7.17.2 Incyte Corporation Business Overview
  7.17.3 Incyte Corporation Ewing Sarcoma Drugs Major Product Offerings
  7.17.4 Incyte Corporation Ewing Sarcoma Drugs Revenue in Global Market (2017-2022)
  7.17.5 Incyte Corporation Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Ewing Sarcoma Drugs Market Opportunities & Trends in Global Market
Table 2. Ewing Sarcoma Drugs Market Drivers in Global Market
Table 3. Ewing Sarcoma Drugs Market Restraints in Global Market
Table 4. Key Players of Ewing Sarcoma Drugs in Global Market
Table 5. Top Ewing Sarcoma Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Ewing Sarcoma Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Ewing Sarcoma Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Ewing Sarcoma Drugs Product Type
Table 9. List of Global Tier 1 Ewing Sarcoma Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ewing Sarcoma Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Ewing Sarcoma Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Ewing Sarcoma Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Ewing Sarcoma Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Ewing Sarcoma Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Ewing Sarcoma Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Ewing Sarcoma Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Ewing Sarcoma Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Ewing Sarcoma Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Ewing Sarcoma Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Ewing Sarcoma Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Ewing Sarcoma Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Ewing Sarcoma Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Ewing Sarcoma Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Ewing Sarcoma Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Ewing Sarcoma Drugs Product Offerings
Table 32. Merck Ewing Sarcoma Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Roche Corporate Summary
Table 34. Roche Ewing Sarcoma Drugs Product Offerings
Table 35. Roche Ewing Sarcoma Drugs Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline Corporate Summary
Table 37. GlaxoSmithKline Ewing Sarcoma Drugs Product Offerings
Table 38. GlaxoSmithKline Ewing Sarcoma Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Ewing Sarcoma Drugs Product Offerings
Table 41. Novartis Ewing Sarcoma Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Ewing Sarcoma Drugs Product Offerings
Table 44. Pfizer Ewing Sarcoma Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Johnson & Johnson Corporate Summary
Table 46. Johnson & Johnson Ewing Sarcoma Drugs Product Offerings
Table 47. Johnson & Johnson Ewing Sarcoma Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Bristol-Myers Squibb Corporate Summary
Table 49. Bristol-Myers Squibb Ewing Sarcoma Drugs Product Offerings
Table 50. Bristol-Myers Squibb Ewing Sarcoma Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Sanofi Corporate Summary
Table 52. Sanofi Ewing Sarcoma Drugs Product Offerings
Table 53. Sanofi Ewing Sarcoma Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Abbott Corporate Summary
Table 55. Abbott Ewing Sarcoma Drugs Product Offerings
Table 56. Abbott Ewing Sarcoma Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Bausch Health Corporate Summary
Table 58. Bausch Health Ewing Sarcoma Drugs Product Offerings
Table 59. Bausch Health Ewing Sarcoma Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Eli Lilly Corporate Summary
Table 61. Eli Lilly Ewing Sarcoma Drugs Product Offerings
Table 62. Eli Lilly Ewing Sarcoma Drugs Revenue (US$, Mn), (2017-2022)
Table 63. AbbVie Corporate Summary
Table 64. AbbVie Ewing Sarcoma Drugs Product Offerings
Table 65. AbbVie Ewing Sarcoma Drugs Revenue (US$, Mn), (2017-2022)
Table 66. Takeda Pharmaceutical Corporate Summary
Table 67. Takeda Pharmaceutical Ewing Sarcoma Drugs Product Offerings
Table 68. Takeda Pharmaceutical Ewing Sarcoma Drugs Revenue (US$, Mn), (2017-2022)
Table 69. Amgen Corporate Summary
Table 70. Amgen Ewing Sarcoma Drugs Product Offerings
Table 71. Amgen Ewing Sarcoma Drugs Revenue (US$, Mn), (2017-2022)
Table 72. AstraZeneca Corporate Summary
Table 73. AstraZeneca Ewing Sarcoma Drugs Product Offerings
Table 74. AstraZeneca Ewing Sarcoma Drugs Revenue (US$, Mn), (2017-2022)
Table 75. Eisai Corporate Summary
Table 76. Eisai Ewing Sarcoma Drugs Product Offerings
Table 77. Eisai Ewing Sarcoma Drugs Revenue (US$, Mn), (2017-2022)
Table 78. Incyte Corporation Corporate Summary
Table 79. Incyte Corporation Ewing Sarcoma Drugs Product Offerings
Table 80. Incyte Corporation Ewing Sarcoma Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Ewing Sarcoma Drugs Segment by Type in 2021
Figure 2. Ewing Sarcoma Drugs Segment by Application in 2021
Figure 3. Global Ewing Sarcoma Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Ewing Sarcoma Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Ewing Sarcoma Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ewing Sarcoma Drugs Revenue in 2021
Figure 8. By Type - Global Ewing Sarcoma Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Ewing Sarcoma Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Ewing Sarcoma Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Ewing Sarcoma Drugs Revenue Market Share, 2017-2028
Figure 12. US Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Ewing Sarcoma Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Ewing Sarcoma Drugs Revenue Market Share, 2017-2028
Figure 24. China Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Ewing Sarcoma Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Ewing Sarcoma Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Ewing Sarcoma Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Ewing Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Ewing Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline Ewing Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Ewing Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Ewing Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Johnson & Johnson Ewing Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bristol-Myers Squibb Ewing Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sanofi Ewing Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Abbott Ewing Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Bausch Health Ewing Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Eli Lilly Ewing Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. AbbVie Ewing Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Takeda Pharmaceutical Ewing Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Amgen Ewing Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. AstraZeneca Ewing Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Eisai Ewing Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Incyte Corporation Ewing Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)